Clinical Gait Evaluation with Neuromuscular Impairments (Clinical GENI) for spastic cerebral palsy.

ABSTRACT:

Background

Gait abnormalities in spastic cerebral palsy (CP) result from four primary neuromuscular impairments: muscle weakness, short muscle-relative-to-skeletal-length, muscle spasticity, and impaired selective motor control. The Clinical Gait Evaluation with Neuromuscular Impairments (Clinical GENI) was developed to help clinicians identify gait abnormalities and contributing neuromuscular impairments in spastic CP for use in any clinical setting.

Aims

This study evaluated use and validity of the observational-based Clinical GENI to identify gait abnormalities and contributing neuromuscular impairments in children with spastic CP.

Methods

Patients with spastic CP seen in 2023 for instrumented gait analysis and physical exam of neuromuscular impairments were evalua

SUBMITTER: Clewes K 

PROVIDER: S-EPMC12484064 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature